Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 5, 2018Advanced Functional Materials

iRGD Modified Chemo‐immunotherapeutic Nanoparticles for Enhanced Immunotherapy against Glioblastoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJing KuangWSWen SongJYJun Yin

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuang et al. (2018) studied this question.

synapsesocial.com/papers/6a71539bac440176ef2a0100https://doi.org/10.1002/adfm.201800025
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IDO Expression in Brain Tumors Increases the Recruitment of Regulatory T Cells and Negatively Impacts Survival2012 · 477 citations
  2. 2Peptide-22 and Cyclic RGD Functionalized Liposomes for Glioma Targeting Drug Delivery Overcoming BBB and BBTB2017 · 233 citations
  3. 3IDO1 is an Integral Mediator of Inflammatory Neovascularization2016 · 90 citations
  4. 4Combined Delivery of Temozolomide and Anti-miR221 PNA Using Mesoporous Silica Nanoparticles Induces Apoptosis in Resistant Glioma Cells2015 · 143 citations